These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 3808143)

  • 1. Phosphate-binding properties and electrolyte content of aluminum hydroxide antacids.
    Balasa RW; Murray RL; Kondelis NP; Bischel MD
    Nephron; 1987; 45(1):16-21. PubMed ID: 3808143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of buffering capacity and acid neutralizing-pH time profile of antacids.
    Lin MS; Sun P; Yu HY
    J Formos Med Assoc; 1998 Oct; 97(10):704-10. PubMed ID: 9830281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antacid action of the aluminum cation: comparison of the in vitro effect of hydroxide and phosphate in open and closed systems].
    Vatier J; Lionnet F; Vitre MT
    Gastroenterol Clin Biol; 1987 Nov; 11(11):758-63. PubMed ID: 3428519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of antacid suspensions containing aluminum hydroxide and magnesium hydroxide.
    Hem SL; White JL; Buehler JD; Luber JR; Grim WM; Lipka EA
    Am J Hosp Pharm; 1982 Nov; 39(11):1925-30. PubMed ID: 7148862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of pH on in vitro disintegration of phosphate binders.
    Stamatakis MK; Alderman JM; Meyer-Stout PJ
    Am J Kidney Dis; 1998 Nov; 32(5):808-12. PubMed ID: 9820451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding properties in vitro of antacids for conjugated bile acids.
    Clain JE; Malagelada JR; Chadwick VS; Hofmann AF
    Gastroenterology; 1977 Sep; 73(3):556-9. PubMed ID: 19335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antacids--gel or tablet. A randomized, double-blind, placebo-controlled study].
    Schulthess HK; Häcki WH
    Schweiz Med Wochenschr; 1985 Jul; 115(29):1016-9. PubMed ID: 4048899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of antacid tablets and liquid in fasting and fed men and women.
    Thomson AB; Pinchbeck B; Kirdeikis J; Kirdeikis P; Zuk L; Brunet MK; Jurima-Romet M; Murray PE
    Clin Ther; 1988; 10(2):158-68. PubMed ID: 3273863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralizing capacity and cost effectiveness of antacids.
    Drake D; Hollander D
    Ann Intern Med; 1981 Feb; 94(2):215-7. PubMed ID: 6781389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of liquid aluminium phosphate and aluminium hydroxide with the gastric acid profile. Influence of food components and timing of meals.
    Schürer-Maly CC; Varga L; Halter F
    Scand J Gastroenterol; 1992 Apr; 27(4):263-9. PubMed ID: 1589702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical reactivity of aluminium-based pharmaceutical compounds used as phosphate-binders.
    Cargill RW; Dutkowskij M; Prescott A; Fleming LW; Stewart WK
    J Pharm Pharmacol; 1989 Jan; 41(1):11-6. PubMed ID: 2565957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antacid activity of calcium carbonate and hydrotalcite tablets. Comparison between in vitro evaluation using the "artificial stomach-duodenum" model and in vivo pH-metry in healthy volunteers.
    Vatier J; Ramdani A; Vitré MT; Mignon M
    Arzneimittelforschung; 1994 Apr; 44(4):514-8. PubMed ID: 8011006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biopharmaceutical properties of liquid and tablet antacids: in vivo studies using the intragastric pH-measurement technique.
    Brouwers JR; Tygat GN
    J Pharm Pharmacol; 1978 Mar; 30(3):148-51. PubMed ID: 24686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum and urine electrolyte behavior under therapeutic dosage of a potent magnesium and aluminum hydroxide containing antacid].
    Grünzig G; Lücker PW; Schnitker J
    Arzneimittelforschung; 1983; 33(2):258-62. PubMed ID: 6682667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of antacid compounds containing both aluminum and magnesium. II. Codried powders.
    Peterson CL; Perry DL; Masood H; White JL; Hem SL; Fritsch C; Haeusler F
    Pharm Res; 1993 Jul; 10(7):1005-7. PubMed ID: 8378241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adsorption of bile acids by sucralfate, antacids, and cholestyramine in vitro.
    Ståhlberg M; Jalovaara P; Laitinen S; Mokka R; Hentilä R; Järvensivu P; Kairaluoma M
    Clin Ther; 1987; 9(6):615-21. PubMed ID: 3440273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of in vitro and in vivo methodology for evaluation of antacids.
    Smyth RD; Herczeg T; Wheatley TA; Hause W; Reavey-Cantwell NH
    J Pharm Sci; 1976 Jul; 65(7):1045-7. PubMed ID: 8626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro comparison of the antacid potencies of almagate in tablets and suspension with those of other commercially available antacid preparations.
    Prieto R; Martinez-Tobed A; Fábregas JL; Beneyto JE
    Arzneimittelforschung; 1984; 34(10A):1360-4. PubMed ID: 6548920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the impairment of renal function and of the pH of gastric secretion on the efficacy of Al(OH)3 to reduce serum inorganic phosphorus.
    Barsotti G; Lazzeri M; Polloni A; Morelli E; Giovannetti E; Lupetti S; Cupisti A; Dani L; Giovannetti S
    Adv Exp Med Biol; 1986; 208():493-9. PubMed ID: 3565160
    [No Abstract]   [Full Text] [Related]  

  • 20. Acid-neutralizing capacity and sodium content of antacid products from Belgium.
    Gombatz VW
    Clin Ther; 1984; 6(2):151-4. PubMed ID: 6705010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.